NPS RADAR December 2005NPS RADAR December 2005

NPS RADAR articles provide timely, independent, evidence-based assessment of new drugs, new PBS listings and research for health professionals.

Find out more about NPS RADAR.



Title Why read this
NPS RADAR December 2005 Professional publication - NPS RADAR - Complete issue NPS RADAR articles provide timely, independent, evidence-based assessment of new drugs, new PBS listings and research for health professionals.
Anastrozole (Arimidex) for breast cancer in postmenopausal women Professional publication - NPS RADAR - Review Reports on PBS listing extension of anastrozole to include all postmenopausal women with hormone-dependent early breast cancer and compares anastrozole with tamoxifen.
Atorvastatin (Lipitor) for the management of lipid disorders Professional publication - NPS RADAR - Review Reviews use of atorvastatin for hyperlipidaemia, including comparison with simvastatin and pravastatin. Risk of myopathy and rhabdomyolysis is similar to that from other statins.
Buprenorphine transdermal patches (Norspan) for chronic severe pain Professional publication - NPS RADAR - Review Reviews use of buprenorphine skin patches for chronic severe non-cancer pain, including adverse effects, contraindications, and treatment of overdose.
Metformin/glibenclamide (Glucovance) for type 2 diabetes mellitus Professional publication - NPS RADAR - Review Reviews use of metformin/glibenclamide combination tablets for type 2 diabetes mellitus, including comparison with co-administered drugs and risk of hypoglycaemia.

Complete list of all NPS RADAR content.

Find out more about NPS RADAR.

Date published: 2005-12-01 00:00:00

Reasonable care is taken to provide accurate information at the date of creation. This information is not intended as a substitute for medical advice from a qualified health professional. Health professionals should rely on their own expertise and enquiries when providing medical advice or treatment. Where permitted by law, NPS disclaims all liability (including for negligence) for any loss, damage or injury resulting from reliance on or use of this information. Read our full disclaimer.

References to brands should not be taken as an endorsement by NPS.